Today: 30 April 2026
Nu Holdings stock steadies near $18 as Brazil rate call and Fed meeting loom next week
24 January 2026
2 mins read

Nu Holdings stock steadies near $18 as Brazil rate call and Fed meeting loom next week

New York, Jan 24, 2026, 07:27 EST — Market closed

  • Nu Holdings shares ended Friday up 0.2% at $18.04 but slipped to $18.00 in after-hours trading.
  • Brazil’s central bank is set to decide on Jan. 28. Most economists expect rates to hold at 15%, with cuts likely beginning in March.
  • Nu is set to release its fourth-quarter results on Feb. 25, marking its next major catalyst.

Nu Holdings shares closed Friday just above the flatline, up 0.2% at $18.04. After-hours saw a slight pullback to $18.00.

With U.S. markets closed over the weekend, Monday’s focus falls squarely on the macro calendar. For a digital lender connected to Brazil’s credit cycle, any shift in rate signals can quickly change the outlook — impacting everything from funding costs to loan demand.

Brazil’s central bank is set to hold the Selic benchmark rate steady at 15% during its Jan. 28 meeting, a Reuters poll shows. Citi analysts point to easing inflation expectations and a slowdown in current inflation as reasons for Copom to begin rate cuts in March. Stephan Kautz, chief economist at EQI Asset, noted that any tweaks in the post-meeting statement might signal a shift in policy stance.

The Federal Reserve will convene on Jan. 27-28, with its rate decision and press conference set for Wednesday. Any hawkish surprise could push U.S. yields higher, tighten dollar funding, and curb demand for emerging-market risk.

Nu is pushing its brand well past banking. The company just announced a multi-year deal with the Mercedes-AMG PETRONAS Formula One team. Co-founder Cristina Junqueira called it an opportunity to “connect with hundreds of millions of fans” in Brazil, Mexico, Colombia, the United States, and further afield. Mercedes-AMG PETRONAS F1 Team

Risk appetite heading into the weekend remained fragile. The Dow dropped Friday, while the Nasdaq eked out a gain, shaken by Intel’s gloomy forecast. Jason Blackwell, chief investment strategist at Focus Partners Wealth, noted investors still felt “pretty good” but braced for “twists and turns” this year. Reuters

Nu traded in a range from $17.72 to $18.06 on Friday, with roughly 63 million shares exchanging hands. Despite heavy volume, the stock ended the day nearly flat, highlighting how fast sentiment can shift in high-growth financial stocks.

The next major company-specific event is earnings. Nu’s investor relations calendar shows its fourth-quarter results and conference call set for Feb. 25.

That report will probably shift attention back to fundamentals: net interest margin — the gap between what banks earn on loans versus what they pay on deposits — and the trajectory of credit costs. Insights on pricing, defaults, and funding in Brazil will carry weight, particularly as markets gauge the Selic’s next move.

The rate story could also flip. Should inflation remain stubborn and Copom hold a hawkish stance beyond economists’ forecasts, loan growth might stall and losses climb. Meanwhile, a stronger dollar usually weighs on emerging-market trades.

Traders enter the new week focused on three key dates: the Fed and Copom decisions on Jan. 28, plus Nu’s earnings on Feb. 25. How those statements sound could be just as important as the actual figures.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Costco stock (COST) holds near $1,000 as dividend date nears and a sales update looms
Previous Story

Costco stock (COST) holds near $1,000 as dividend date nears and a sales update looms

Applied Digital (APLD) stock jumps on 430MW Delta Forge AI data center kickoff as traders eye next catalysts
Next Story

Applied Digital (APLD) stock jumps on 430MW Delta Forge AI data center kickoff as traders eye next catalysts

Go toTop